Valid questions. I also posted a question yesterday to see if any of the DD Kings had any info around their business model post approval. No response. It concerns me a little that they have a physician as their COO. Hopefully they will be working on an appropriate organizational structure to manage the post approval company. I am long and also think this could be a double digit company in the long run. 20 30 who knows. Should Google really have a 400 B market cap? Or Celgene a 59 B. Only time will tell.
Styl...i think we are all on same page with nvlx.. future pps is unknown and no one can predict where we will be....but i am here for the long haul...been here for many years already and I want to see it play fully out...given that I will say...If cell in box is successful in giving pancreatic cancer sufferers double what the current treatment (abraxane or gemzar) gives...we should see pps in the dollars....i say this because by that time we will be involved in CTS involving cell in box and diabetes and possibly mj...any hint that cell in box helps diabetes and this pps will skyrocket...mj adds to it if successful. ..patience.
News 
Market Data 
Discover 
